In this episode, we are joined by Mark Stewart from Friends of Cancer Research (Friends
). Victor and Mark discuss how Tumor Mutational Burden (TMB) is different from other complex biomarkers, such as Microsatellite Instability (MSI), and the importance of standardizing these biomarkers to reference standards.
They also talk about the Friends
TMB harmonization project and how this project could lead to advancements in cancer research.
To learn more about Friends of Cancer Research (Friends
), visit www.focr.org